Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

NCT06943235 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Limited Stage Small Cell Lung Cancer

Interventions

DRUG: Probiotics
RADIATION: concurrent Hyperfractionated Radiotherapy
DRUG: Immunotherapy

Sponsor

Fudan University